Methotrexate in the treatment of systemic sclerosis
Reading time: 3 minutes
One study (n=29) 1 compared methotrexate (MTX) with placebo in the treatment of systemic sclerosis (SSc) in a 24 week randomized double-blind trial, followed ...
Do you want to read more?
To continue reading this article, you must log in with your personal, organization, or group practice subscription.
For more information or to purchase a personal subscription, click below to see pricing.
{{branchArticle.articleDatabase.name}}
Article ID:{{branchArticle.id}}
{{branchArticle.publishedStr}}
Authors: {{branchArticle.authors}}
Copyright © Dental Mammoth. All Rights Reserved
Copyright © Duodecim Medical Publications Ltd. 2018. All Rights Reserved
Table of contents
Do you want to read more?
To continue reading this article, you must log in with your personal, organization, or group practice subscription.
For more information or to purchase a personal subscription, click below to see pricing.
Evidence Summaries
Article ID: evd06807
Published 06.04.2011
Authors: Editors
Copyright © Duodecim Medical Publications Ltd. All Rights Reserved
{{selectedMetadata.pluginDescription || selectedMetadata.metaId}}
{{metaDataError}}
|
|